• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

FDA starts speedy review of Servier's Tibsovo in MDS

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 17, 2023 at 10:12: AM
via Servier could become the first company to bring an IDH inhibitor to market in the US for patients with myelodysplastic syndromes (MDS) next year, after the FDA started a priority review of its Tibsovo drug in this indication.

article source
 

<



Similar threads

cafead
FDA starts speedy review of Amgen’s lung cancer BiTE therapy
Replies
0
Views
95
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA starts speedy review of Enhertu in lung cancer
Replies
0
Views
198
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Eli Lilly kick-starts speedy FDA review for Alzheimer&#039;s hopeful donanemab—and a...
Replies
0
Views
151
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA starts speedy review of Keytruda for adjuvant kidney cancer
Replies
0
Views
163
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA starts speedy review of Loxo’s site-agnostic cancer drug larotrectinib
Replies
0
Views
203
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote